)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Hualan Biological Engineering
Hualan Biological Engineering (002007) investor relations material
Hualan Biological Engineering H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary28 Mar, 2026
Executive summary
Revenue for 2025 reached ¥4.60 billion, up 4.93% year-over-year; net profit attributable to shareholders was ¥940 million, down 13.55% year-over-year.
Blood products remained the core business, accounting for 73.71% of revenue; vaccine products contributed 26.01%.
Cash dividend of ¥5 per 10 shares proposed, with a payout ratio of 97.16% of annual net profit.
R&D investment increased to ¥338 million, focusing on new blood products, vaccines, and innovative biologics.
Financial highlights
Operating income: ¥4.60 billion, up 4.93% year-over-year.
Net profit attributable to shareholders: ¥940 million, down 13.55% year-over-year.
Gross margin for blood products: 50.17%; for vaccines: 78.38%.
Operating cash flow: ¥878 million, down 17.12% year-over-year.
Total assets at year-end: ¥15.26 billion, down 6.42% from prior year.
Basic and diluted EPS: ¥0.5151, down 13.54% year-over-year.
Outlook and guidance
Plans to expand plasma collection capacity and apply for new plasma stations.
Continued focus on R&D for innovative drugs, vaccines, and biologics, aiming to accelerate product launches.
Intends to strengthen international market expansion for immunoglobulin and influenza vaccines.
疫苗制品生产量下降对单位成本及毛利率的影响
GLP-1类在研药物及创新药管线最新进展
十五五期间新建单采血浆站的申请规划
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Hualan Biological Engineering
- Net profit fell 26.6% as vaccine sales dropped, but blood products revenue grew 10.9%.002007
H2 202419 Dec 2025 - Q3 2025 saw a 14% revenue drop and 44.45% net profit decline year-over-year.002007Q3 202530 Oct 2025
- Net profit rose 17.2% year-over-year on strong blood product sales and higher R&D investment.002007H1 202528 Aug 2025
- Revenue and profit fell in Q3 2024, with cash flow and working capital under pressure.002007Q3 202413 Jun 2025
- Revenue up, profit down as vaccine sales drop and blood products drive growth.002007H1 202413 Jun 2025
- Revenue and net profit rose, but cash flow weakened amid higher investment outflows.002007Q1 20256 Jun 2025
Hualan Biological Engineering
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage